The evolving role of regulatory T cells in pulmonary diseases: immunomodulatory mechanisms and translational directions revealed by bibliometric analysis - Report - MDSpire
Advertisement
The evolving role of regulatory T cells in pulmonary diseases: immunomodulatory mechanisms and translational directions revealed by bibliometric analysis
Clinical Report: The Changing Function of Regulatory T Cells in Lung Diseases
Overview
This bibliometric analysis characterizes the evolving landscape of regulatory T cell (Treg) research in pulmonary diseases, highlighting significant growth trends and thematic shifts. Key findings indicate a transition towards translational topics such as immunotherapy and microbiota-associated immune regulation.
Background
Regulatory T cells (Tregs) are crucial for maintaining immune homeostasis and play significant roles in the progression of various pulmonary diseases. Understanding the dynamics of Treg research is essential for developing targeted therapies and improving patient outcomes in conditions like asthma, COPD, and lung cancer. The recent surge in Treg studies underscores the need for a comprehensive overview of current trends and future directions in this field.
Data Highlights
No numerical data available in the article.
Key Findings
The research on Tregs in pulmonary diseases has shown a tri-phasic growth pattern from 2000 to 2025.
The United States was the leading contributor in the early years, while China has become the top producer since 2021.
Keyword co-occurrence analysis indicates a shift from foundational immune regulation to topics like immunotherapy and chronic inflammatory lung diseases.
Emerging therapeutic strategies targeting Tregs and the tumor microenvironment are gaining attention in the literature.
Dysregulation of Tregs is associated with various pulmonary diseases, including asthma, COPD, and lung cancer.
Clinical Implications
The findings suggest that targeting Tregs may offer new therapeutic avenues for managing pulmonary diseases. Clinicians should consider the evolving role of Tregs in disease mechanisms when developing treatment strategies, particularly in the context of immunotherapy.
Conclusion
This analysis provides valuable insights into the trends and emerging frontiers of Treg research in pulmonary diseases, emphasizing the potential for innovative therapeutic approaches in the future.
